2020
DOI: 10.1038/s41372-020-0649-6
|View full text |Cite
|
Sign up to set email alerts
|

Can we improve early identification of neonatal late-onset sepsis? A validated prediction model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
27
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(29 citation statements)
references
References 27 publications
1
27
0
1
Order By: Relevance
“…As is current practice in sepsis (Farkas, 2020;Goldberg et al, 2020), tuberculosis (Abakay et al, 2015), and reactive forms of leprosy (Gomes et al, 2020), biomarkers are being widely discussed and proposed as tests that complement the clinical decision making to predict the presence of severity in infections (Jager et al, 2012). Among the various parameters related to leukocytes in the bloodstream, the neutrophil/lymphocyte ratio (NLR) stands out for being a biomarker that is easily obtained and available in clinical practice, in addition to being significantly associated with systemic inflammation (Benites-Zapata et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As is current practice in sepsis (Farkas, 2020;Goldberg et al, 2020), tuberculosis (Abakay et al, 2015), and reactive forms of leprosy (Gomes et al, 2020), biomarkers are being widely discussed and proposed as tests that complement the clinical decision making to predict the presence of severity in infections (Jager et al, 2012). Among the various parameters related to leukocytes in the bloodstream, the neutrophil/lymphocyte ratio (NLR) stands out for being a biomarker that is easily obtained and available in clinical practice, in addition to being significantly associated with systemic inflammation (Benites-Zapata et al, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Similar to other infectious diseases like sepsis (Farkas, 2020;Goldberg et al, 2020), tuberculosis (Abakay et al, 2015), and reactive forms of leprosy (Gomes et al, 2020), biomarkers have been widely discussed and proposed as complementary tests to support a more assertive clinical decision. Similar to the importance of serum lactate in the management of sepsis, we aim to find a biomarker that can be easily obtained even in the most remote clinical laboratories in remote areas of Brazil and in other Latin American countries Currently, there are no laboratory biomarkers available to support clinical decision-making when differentiating between severe and non-severe patients with PCM, and that, consequently, culminates in the prescription of oral antifungal drugs orally for non-severe patients at the time of admission, or intravenous medication, associated with other hospital support care, for critically ill patients.…”
Section: Introductionmentioning
confidence: 99%
“…Disagreement between evaluating neonatologists was resolved by discussion or consulting a third neonatologist until consensus was achieved. The heath evaluation score ( Appendix 1 ) was graded into three groups as follows: healthy, equivocal, or sick appearing ( 11 ) and is similar to the classification of clinical signs used routinely to evaluate early-onset sepsis ( 12 , 13 ).…”
Section: Methodsmentioning
confidence: 99%
“…The study definitions have been previously described in detail ( 11 ). LOS was defined by a single positive blood culture by a causative pathogen 72 h or later after birth, with the exception of sepsis caused by coagulase negative staphylococci, which required two positive blood cultures.…”
Section: Methodsmentioning
confidence: 99%
“…[14][15][16] There have been also recent publications on its use in the neonatal population for its prognosticative value in the evaluation of neonatal sepsis. [17][18][19][20] However, studies on its use in the pediatric population in the evaluation of infection severity is very limited.…”
Section: Introductionmentioning
confidence: 99%